Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Melanoma 25Hodgkin Disease 20Lymphoma 9Skin Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Leiomyosarcoma 3Neuroblastoma 2Neoplasms 2Uveal Melanoma 1Skin Diseases 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Melanoma, Cutaneous Malignant 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Liposarcoma 1

Interventions

Cyclophosphamide 21Carboplatin 17Etoposide 15Doxorubicin 14Vincristine 13Cisplatin 11Melphalan 10Filgrastim 10Radiotherapy 9Isotretinoin 8Topotecan 7Peripheral Blood Stem Cell Transplantation 6Granulocyte Colony-Stimulating Factor 6dinutuximab 5sargramostim 4etoposide phosphate 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4Busulfan 4Vindesine 3Thiotepa 3Platinum 3Ifosfamide 3Colony-Stimulating Factors 3Chemotherapy, Adjuvant 3Biopsy 33-Iodobenzylguanidine 31,2-diaminocyclohexaneplatinum II citrate 3liposomal amphotericin B 2fluorodopa F 18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neuroblastoma × Dacarbazine × Clear all
NCT00002802 2013-12-19

Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Completed
500 enrolled
CNS

Neuroblastoma

NCT00410631 2013-08-07

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
642 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡